MTHFD2 and cancer: Because MTHFD2 is upregulated and drives cancer progression in a wide variety of tumors, and its expression is low in proliferative and differentiated adult tissues12,15, this enzyme has become very attractive for the development of novel, metabolically-targeted cancer therapies.